Don Weissman, MD

Life Sciences and Healthcare

Medical & Regulatory Affairs
KOL Relationships, Strategy, Governance

Senior Medical Science Liaison


   Initiatives, Alliances, Partnerships 

   Better Healthcare, Longevity, Quality of Life * Best Outcomes



Entrepreneurial Physician 

  Medical and Regulatory Affairs 

   KOL Relationships and Governance

  Strategic Business and Market Development

   Bio-Pharmaceuticals, Technologies, Devices

Diagnostics and Services.

Excellent KOL, HCP and C level relationships, 

 communications and development 

across the Life Sciences and Healthcare, 

Academic, Corporate and Clinical. 

Proven track record of success helping Life Science Companies 

and Healthcare Institutions accelerate product development,

and optimize market success for patient benefits, 

better outcomes and quality of life, 

caretaker, provider and stakeholder values. 


Exceptional education, presentations

communications and interpersonal skills.

Key Opinion Leader insights and 

 scientific exchange, for trials, data analytics

 applications, adoption and advocacy.

Advisory Board Development, Honored Society

 and Board Relationships with Subject Matter Experts,

 Academic & University Medical Centers, 

Physicians of Influence and Healthcare Decision Makers.


Analyst, Grant review and panel member for the

 National Science Foundation, the NSF 
National Institute of Health the NIH and Department of Health 

& Human Services: biomedical research, diagnostics, genomics

bio-pharmaceuticals, devices and innovative therapeutics.

Adept listener, articulate and persuasive, 
building professional consensus for 
trials, applications, approvals and advocacy,
greater compliance and adherence, understanding
needs, drivers and implementations for success. 
In-depth Medical and Regulatory affairs, 
pharmaco-economics, HEOR and vigilance for resource
allocation and guidelines. Highly successful with the FDA, FTC,
PhRMA, AHRQ and CMS. Proven track record of success for coverage
and reimbursements by government, insurance, payers and plans.

Honored society, academic and board relationships for strategic CME,
regional and national symposium, publications, brand
and market development, mobile and social media
applications with validation. 


Extraordinary resources, knowledge and success

developing and strengthening internal and external 

partnerships and alliances with renowned KOL's, academic, 

 corporate, government and clinical leaders.





Innovative therapeutics, diagnostics and services

to treat, ameliorate, cure and prevent.


To optimize patient well being and quality of life

in clinical, operational and financial outcomes.